Nov 27, 2021

Starpharma reports positive interim results from Phase 2 DEP cabazitaxel study in prostate cancer

Starpharma's positive interim results from its ongoing phase 2 trial of DEP cabazitaxel featured in Seeking Alpha. Read the full article here.

 This contains certain forward-looking statements.